This morning, the Food and Drug Administration (FDA) updated the Emergency Use Authorizations (EUA) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to authorize a booster dose for all adults 18 years of age and older at least 6 months after their primary series.

Late today, Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed the Advisory Committee on Immunization Practices’ recommendation that booster doses of these vaccines be available to all adults.

Vaccine providers may immediately begin administering booster doses to all adults ages 18 years and older.

Note: The Moderna COVID-19 booster dose is half of the dose (50 mcg or 0.25 mL) that is administered for the primary series dose.

For individuals who received the Johnson & Johnson COVID-19 vaccine, booster shots continue to be recommended for those who are 18 and older and least two months after vaccination.

Regardless of which vaccine people got for their primary series, they may choose any authorized vaccine for their booster (mix-and-match).

DSHS recommends that people consult a healthcare provider if they have questions about their risks from COVID-19 and whether a booster dose would be beneficial for them.

Thank you for your continued diligence in vaccinating all eligible Texans who would like to be vaccinated.

Resources:

Pfizer COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers

Pfizer COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers

Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers

Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers

J&J/Janssen COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers

J&J/Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers

Texas Department of State Health Services

This service is provided to you at no charge by the Texas Department of State Health Services.

Visit us on the web at http://www.dshs.texas.gov.